BridgeMD
New treatment option for Rectal Cancer
Official title Watchful Waiting for Complete Responders to Therapy in Rectal Cancer
ClinicalTrials.gov ID: NCT05526079
What this study is testing
- What it's testing
- The purpose of this project is to determine if in a selected group of patients, at higher risk of wound dehiscence and other complications, treatment by local excision and management by a "watchful waiting" or an initial "non-operative management" approach, with an offer of radical resection only to those patients whose tumors demonstrate "regrowth" will maintain acceptable local control and overall survival rate for the whole cohort.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 95
You may be able to join if
- Age ≥ 18 years
- Diagnosis of rectal invasive adenocarcinoma
- Tumor in the low rectum lying \< 4 cm from the anal verge
- Clinical stage T3/N0-N1M0.
- Patients with low T2 who will need abdominal perineal resection are also eligible.
You likely can't join if
- Age less than 18 years
- Other forms of cancer
- Tumors \>= 4 cm from the anal verge
- Tumors of other clinical stages than listed above
The study team makes the final eligibility decision.
Where it's taking place
- Detroit, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 95 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Detroit, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.